lungcancer
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: -Patients with indication for diagnostic bronchoscopy for suspected or proven lung cancer. -ASA physical status 1-3. -Age 18 years or older.
Exclusion criteria
Exclusion criteria: -Bleeding disorders. -Indication for use of anticoagulant therapy (acenocoumarol, warfarin, therapeutic dose of low molecular weight heparines or clopidrogel). -Known allergy for lidocaine. -Known pulmonary hypertension. -Recent and/or uncontrolled cardiac disease. -Compromised upper airway (eg concomitant head and neck cancer or central airway stenosis for any reason). -ASA classification greater than or equal to 4. -Pregnancy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Determing the positive predictive value and diagnostic yield of HD+ i-scan bronchoscopy for vascular pattern detection compared to histology. | — |
Secondary
| Measure | Time frame |
|---|---|
| • To investigate the correlation of vascular abnormalities with histology • To investigate the impact of i-scan technology on the clinical approach or follow-up plan • To investigate the interobserver variability • Investigate diagnostic performance and determing the positive predictive value of HD+ i-scan bronchoscopy in comparison to normal HD-WL on demarcation of tumour margins | — |
Countries
Netherlands